These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

406 related articles for article (PubMed ID: 23150176)

  • 21. Expression and functional role of miR-29b in renal cell carcinoma.
    Xu Y; Zhu J; Lei Z; Wan L; Zhu X; Ye F; Tong Y
    Int J Clin Exp Pathol; 2015; 8(11):14161-70. PubMed ID: 26823729
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long intergenic non-coding RNA 1939 eliminates proliferation and migration of human renal cell carcinoma (RCC) cells by down-regulation of miR-154.
    Zhang R; Zhang W; Xu B; Lv C; Hou J; Zhang G
    Artif Cells Nanomed Biotechnol; 2020 Dec; 48(1):695-702. PubMed ID: 32138544
    [TBL] [Abstract][Full Text] [Related]  

  • 23. LncRNA HOTAIR regulates HIF-1α/AXL signaling through inhibition of miR-217 in renal cell carcinoma.
    Hong Q; Li O; Zheng W; Xiao WZ; Zhang L; Wu D; Cai GY; He JC; Chen XM
    Cell Death Dis; 2017 May; 8(5):e2772. PubMed ID: 28492542
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cooperative Effect of miR-141-3p and miR-145-5p in the Regulation of Targets in Clear Cell Renal Cell Carcinoma.
    Liep J; Kilic E; Meyer HA; Busch J; Jung K; Rabien A
    PLoS One; 2016; 11(6):e0157801. PubMed ID: 27336447
    [TBL] [Abstract][Full Text] [Related]  

  • 25. miR-130b Promotes Sunitinib Resistance through Regulation of PTEN in Renal Cell Carcinoma.
    Sekino Y; Sakamoto N; Sentani K; Oue N; Teishima J; Matsubara A; Yasui W
    Oncology; 2019; 97(3):164-172. PubMed ID: 31195398
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of MicroRNAs associated with early relapse after nephrectomy in renal cell carcinoma patients.
    Slaby O; Redova M; Poprach A; Nekvindova J; Iliev R; Radova L; Lakomy R; Svoboda M; Vyzula R
    Genes Chromosomes Cancer; 2012 Jul; 51(7):707-16. PubMed ID: 22492545
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MicroRNA-509-3p inhibits cancer cell proliferation and migration by targeting the mitogen-activated protein kinase kinase kinase 8 oncogene in renal cell carcinoma.
    Su Z; Chen D; Zhang E; Li Y; Yu Z; Shi M; Jiang Z; Ni L; Yang S; Gui Y; Ye J; Lai Y
    Mol Med Rep; 2015 Jul; 12(1):1535-43. PubMed ID: 25815776
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Molecular Characterization of Renal Cell Carcinoma: A Potential Three-MicroRNA Prognostic Signature.
    Lokeshwar SD; Talukder A; Yates TJ; Hennig MJP; Garcia-Roig M; Lahorewala SS; Mullani NN; Klaassen Z; Kava BR; Manoharan M; Soloway MS; Lokeshwar VB
    Cancer Epidemiol Biomarkers Prev; 2018 Apr; 27(4):464-472. PubMed ID: 29440068
    [No Abstract]   [Full Text] [Related]  

  • 29. Oncogene miR-154-5p regulates cellular function and acts as a molecular marker with poor prognosis in renal cell carcinoma.
    Lin C; Li Z; Chen P; Quan J; Pan X; Zhao L; Zhou L; Lai Y; He T; Xu W; Xu J; Guan X; Li H; Yang S; Hu Y; Lai Y
    Life Sci; 2018 Sep; 209():481-489. PubMed ID: 30138594
    [TBL] [Abstract][Full Text] [Related]  

  • 30. miR-96 suppresses renal cell carcinoma invasion via downregulation of Ezrin expression.
    Yu N; Fu S; Liu Y; Xu Z; Liu Y; Hao J; Wang B; Zhang A
    J Exp Clin Cancer Res; 2015 Sep; 34():107. PubMed ID: 26419932
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MicroRNA expression profiling of Xp11 renal cell carcinoma.
    Marchionni L; Hayashi M; Guida E; Ooki A; Munari E; Jabboure FJ; Dinalankara W; Raza A; Netto GJ; Hoque MO; Argani P
    Hum Pathol; 2017 Sep; 67():18-29. PubMed ID: 28411178
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Downregulation of microRNA-15a suppresses the proliferation and invasion of renal cell carcinoma via direct targeting of eIF4E.
    Li G; Chong T; Xiang X; Yang J; Li H
    Oncol Rep; 2017 Oct; 38(4):1995-2002. PubMed ID: 28849086
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tumor suppressive microRNA‑138 contributes to cell migration and invasion through its targeting of vimentin in renal cell carcinoma.
    Yamasaki T; Seki N; Yamada Y; Yoshino H; Hidaka H; Chiyomaru T; Nohata N; Kinoshita T; Nakagawa M; Enokida H
    Int J Oncol; 2012 Sep; 41(3):805-17. PubMed ID: 22766839
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MiR-23a-3p acts as an oncogene and potential prognostic biomarker by targeting PNRC2 in RCC.
    Quan J; Pan X; Li Y; Hu Y; Tao L; Li Z; Zhao L; Wang J; Li H; Lai Y; Zhou L; Lin C; Gui Y; Ye J; Zhang F; Lai Y
    Biomed Pharmacother; 2019 Feb; 110():656-666. PubMed ID: 30551118
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MicroRNA‑222‑3p promotes tumor cell migration and invasion and inhibits apoptosis, and is correlated with an unfavorable prognosis of patients with renal cell carcinoma.
    Zhao L; Quan J; Li Z; Pan X; Wang J; Xu J; Xu W; Guan X; Li H; Yang S; Gui Y; Chen Y; Lai Y
    Int J Mol Med; 2019 Jan; 43(1):525-534. PubMed ID: 30320376
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MicroRNA-20b-5p functions as a tumor suppressor in renal cell carcinoma by regulating cellular proliferation, migration and apoptosis.
    Li Y; Chen D; Jin L; Liu J; Su Z; Li Y; Gui Y; Lai Y
    Mol Med Rep; 2016 Feb; 13(2):1895-901. PubMed ID: 26708577
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tumor-suppressive microRNA-1291 directly regulates glucose transporter 1 in renal cell carcinoma.
    Yamasaki T; Seki N; Yoshino H; Itesako T; Yamada Y; Tatarano S; Hidaka H; Yonezawa T; Nakagawa M; Enokida H
    Cancer Sci; 2013 Nov; 104(11):1411-9. PubMed ID: 23889809
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The circular RNA-NRIP1 plays oncogenic roles by targeting microRNA-505 in the renal carcinoma cell lines.
    Dong Z; Liu Y; Wang Q; Wang H; Ji J; Huang T; Khanal A; Niu H; Cao Y
    J Cell Biochem; 2020 Mar; 121(3):2236-2246. PubMed ID: 31692056
    [TBL] [Abstract][Full Text] [Related]  

  • 39. miR-141 is a key regulator of renal cell carcinoma proliferation and metastasis by controlling EphA2 expression.
    Chen X; Wang X; Ruan A; Han W; Zhao Y; Lu X; Xiao P; Shi H; Wang R; Chen L; Chen S; Du Q; Yang H; Zhang X
    Clin Cancer Res; 2014 May; 20(10):2617-30. PubMed ID: 24647573
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sunitinib-suppressed miR-452-5p facilitates renal cancer cell invasion and metastasis through modulating SMAD4/SMAD7 signals.
    Zhai W; Li S; Zhang J; Chen Y; Ma J; Kong W; Gong D; Zheng J; Xue W; Xu Y
    Mol Cancer; 2018 Nov; 17(1):157. PubMed ID: 30419914
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.